|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Top Lists |
Insider Trading Graph View |
Insider Watch |
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise" - Peter Lynch ==>> What is insider trading>> |

| Transaction & Date | Reported Date |
Company | Symbol | Insider Relationship |
Shares Traded | Average Price | Total Amount |
Shares Ownership |
Filing |
| 2009-05-18 Purchase |
2009-05-19 3:59 pm | AspenBio Pharma, Inc. | APPY | CASPARI ROBERT FREDERICK (COO & Chief Medical Officer) | 3,200 | $1.57 | $5,024 | 3,200 (Direct) | View |
| 2006-11-17 Sale |
2006-11-21 8:04 pm | MYOGEN INC | MYOG | CASPARI ROBERT FREDERICK (Former SVP, Comm Operations) | 92 | $0 | $0 | 0 (Direct) |
View |
| Transaction & Date | Reported Date |
Exercisable Expiration | Company | Symbol | Insider Relationship |
Shares Traded |
Conversion Price | Shares Ownership |
Filing |
| 2006-11-14 Option Sale | 2006-11-17 8:59 pm |
2007-03-03 2016-03-02 | MYOGEN INC | MYOG | CASPARI ROBERT FREDERICK (SVP, Commercial Operations) | 9,760 | $40.98 | 0 (Direct) | View |
| 2006-11-14 Option Sale | 2006-11-17 8:59 pm | 2007-03-03 2016-03-02 | MYOGEN INC | MYOG | CASPARI ROBERT FREDERICK (SVP, Commercial Operations) | 140,240 | $40.98 | 0 (Direct) |
View |
| 2006-11-14 Option Sale |
2006-11-16 9:57 pm | 2007-03-03 2016-03-02 |
MYOGEN INC | MYOG | CASPARI ROBERT FREDERICK (SVP, Commercial Operations) | 9,760 | $40.98 | 0 (Direct) | View |
| 2006-11-14 Option Sale | 2006-11-16 9:57 pm |
2007-03-03 2016-03-02 | MYOGEN INC | MYOG | CASPARI ROBERT FREDERICK (SVP, Commercial Operations) | 140,240 | $40.98 | 0 (Direct) | View |
|
© 2005-2009 SecForm4.Com All rights reserved. Archives: 2009 2008 2007 2006 2005 2004 ... Sat, 21 Nov 2009 00:32:32 -0600 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC. SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |